MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0063122
Innovativ Biosciences Private Limited
Innovativ Biosciences Private Limited - healthcare in Navi Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.59 Cr
▲ 1% YoY
Net profit · FY 2025
₹8,697
Net margin 0.1%
EBITDA · FY 2025
₹91,539
EBITDA margin 0.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹6.01 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Innovativ Biosciences Private Limited
Data last updated:
Innovativ Biosciences Private Limited is a private limited company based in Navi Mumbai, Maharashtra, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 28 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52601MH2016PTC280289. Its GSTIN is 27AAECI1155M1ZF (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shraddha Rupesh Yeola and Rupesh Ratnakar Yeola.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sai Mauli Hospital Plot No 107 Sector 1 Ghansoli, Navi Mumbai, Maharashtra, India – 400701.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.59 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹8,697 (net margin 0.1%) and EBITDA of ₹91,539 (EBITDA margin 0.6%). Revenue has grown at a compounded annual rate (CAGR) of 25% over three years and 6% over five years.
As per MCA filings, the company has open charges of ₹6.01 Lakh on record.
Innovativ Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0063122). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U52601MH2016PTC280289
Registration Number 280289
Incorporation Date 28 April 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0063122
Recognitions & Rankings of Innovativ Biosciences
Contact details
Innovativ Biosciences Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSai Mauli Hospital Plot No 107 Sector 1 Ghansoli, Navi Mumbai, Maharashtra, India – 400701
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Innovativ Biosciences Private Limited, buy the company report.
Comprehensive company report
Innovativ Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Innovativ Biosciences is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Innovativ Biosciences Private Limited, buy the company report.
Financials of Innovativ Biosciences Private Limited
FY 2025 filings availableInnovativ Biosciences Private Limited reported revenue of ₹1.59 Cr (up 1% YoY) for FY 2025.
Revenue · FY 2025
₹1.59 Cr ▲ 1%
Net profit · FY 2025
₹8,697 margin 0.1%
EBITDA · FY 2025
₹91,539 margin 0.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▼ 25%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 67%
3 years · compounded
▼ 61%
5 years · compounded
▼ 24%
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 1% growth in the latest year. EBITDA fell 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹91,539 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,697 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.6% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innovativ Biosciences Private Limited, buy the company report.
Board of directors of Innovativ Biosciences Private Limited
Innovativ Biosciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shraddha Rupesh Yeola Also directs: Belrich Pharmaceuticals (OPC) Private Limited | Director | 21 Dec 2017 | 8 Years 10 Months | Current |
| Rupesh Ratnakar Yeola | Director | 28 Apr 2016 | 10 Years 6 Months | Current |
Auditor
Innovativ Biosciences Private Limited is audited by Udit Gopalji Agrawal & Co for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Udit Gopalji Agrawal & Co | FY 2017 | 426792 |
Shareholding
The shareholding of Innovativ Biosciences Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Innovativ Biosciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹6.01 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jul 2021 | 100468383 | Others | ₹6.01 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Innovativ Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innovativ Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Innovativ Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECI1155M1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Innovativ Biosciences Private Limited, buy the company report.
Recent activity
Innovativ Biosciences Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Kuldeep Raghunath Bagad ceased to be Director on 21 Dec 2017.
AGM
Innovativ Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Innovativ Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others amounted to Rs. 6.01 Lakh with Charge ID 100468383 was registered on 27 Jul 2021.
Ceased
Kuldeep Raghunath Bagad ceased to be Director.
Appointed
Shraddha Rupesh Yeola was appointed as Director.
Appointed
Rupesh Ratnakar Yeola was appointed as Director.
Incorporation
28 Apr 2016
Innovativ Biosciences Private Limited was registered on 28 Apr 2016 with Roc Mumbai & aged 10 years 6 months as per MCA records.
Frequently asked questions
Innovativ Biosciences is an active private limited company based in Navi Mumbai, Maharashtra, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 28 April 2016 (10+ years old) and is registered under CIN U52601MH2016PTC280289.
Innovativ Biosciences has 2 current directors:
- Shraddha Rupesh Yeola - Director
- Rupesh Ratnakar Yeola - Director
The latest financial statements of Innovativ Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Innovativ Biosciences is 27AAECI1155M1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Innovativ Biosciences is U52601MH2016PTC280289. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innovativ Biosciences was incorporated on 28 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Kuldeep Raghunath Bagad ceased to be Director on 21 Dec 2017. Shraddha Rupesh Yeola was appointed as Director on 21 Dec 2017. Rupesh Ratnakar Yeola was appointed as Director on 28 Apr 2016.
Yes, Innovativ Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0063122).
The registered office of Innovativ Biosciences is at Sai Mauli Hospital Plot No 107 Sector 1 Ghansoli, Navi Mumbai, Maharashtra, India – 400701.
Innovativ Biosciences operates in the healthcare industry, in the medical consumables and supplies segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages